Erlotinib Impurity 18 Hydrochloride
| Product Name | Erlotinib Impurity 18 Hydrochloride |
|---|---|
| Alternate Names | Erlotinib Impurities, Impurities of Erlotinib |
| CAT No. | CS-P-07863 |
| CAS No. | 299912-61-1 (free base) |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Erlotinib |
| Therapeutic | Anti-Cancer / Oncology |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
Erlotinib impurity 1 | N-Nitroso Erlotinib | N-Nitroso Erlotinib Cyclised compound | Erlotinib Impurity 10 | Erlotinib Impurity 13 | N-(2-Methoxyethyl) Erlotinib | Tetrahydro Erlotinib | Desmethyl Erlotinib Acetate | Erlotinib-N-Oxide | Erlotinib Impurity 11 | Erlotinib impurity, 6-(2-methoxyethoxy)-7-(2-chloroethoxy) | N-(3-Desethynylphenyl)-N-(3-(1-chlorovinyl)phenyl) Erlotinib | Erlotinib Impurity F | Erlotinib Impurity B | Erlotinib impurity K | Erlotinib Aldehyde | Erlotinib impurity I | Erlotinib Impurity 35 HCl salt | Erlotinib impurity, 6-(2-chloroethoxy)-7-(2-methoxyethoxy) | Erlotinib Related Compound A (Base) | Erlotinib Impurity 6 | N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride | Erlotinib Impurity A | Desmethyl Erlotinib Carboxylate Acid | Desethynyl Erlotinib | Erlotinib impurity L | Didesmethyl Erlotinib Hydrochloride | Erlotinib Impurity 19 | Erlotinib Impurity 14 | Erlotinib Amine Impurity | Erlotinib USP Related Compound A | Erlotinib Impurity 17 | Erlotinib Related Compound A |